Default Category
-
Pluggin In the Consumer: The Adoption of Electrically Powered Vehicles in the U.S.
Ofek, Elie; Ribatt, Polly RossCase HBS-510076-EMarketingHow will U.S. consumers respond to the proliferation of alternative-fuel vehicles, such as cars powered partially or completely by electricity, in the coming decade? After a century in which fossil-fuel-powered vehicles dominated the market, it appeared consumers would have an unprecedented level of choice as to the type of car they purchased and drove. Automakers were introducing various models that used electricity for power, and other power so...Starting at €8.20
-
Deloitte: The Challenge of Reconciling Brand Perception with Reality
García Perrote, Juan; de Toro, Juan ManuelCase M-1248-EMarketingDeloitte had grown in recent years to become the sector's leading company and new challenges now presented themselves. The story of Deloitte is a story of growth based on continuous and numerous additions of members and firms to the company. These mergers and incorporations occurred during the second half of the nineteenth century and throughout the twentieth century. Its peak was, firstly, the merger of Touche Ross and Tohmatsu Awoki & Co. in 19...Starting at €8.20
-
Deloitte: el reto de identificar la percepción de la marca con su realidad
García Perrote, Juan; de Toro, Juan ManuelCase M-1248MarketingDeloitte había crecido en los últimos años hasta convertirse en la firma líder de la industria y en los nuevos retos que ahora se presentaban. La historia de Deloitte es una historia de crecimiento basado en continuas y numerosas incorporaciones de socios y firmas a la compañía. Estas fusiones e integraciones se suceden durante la segunda mitad del siglo XIX y durante todo el siglo XX, siendo su punto álgido, en primer lugar, la fusión entre Touc...Starting at €8.20
-
Tengion: Bringing Regenerative Medicine to Life
Ofek, Elie; Ribatt, Polly RossCase HBS-510031-EMarketingTengion is a young biotech company that is at the frontier of regenerative medicine; a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late 2008 Tengion management faces a difficult dilemma. In light of the financial crises, the company needs to manage cash burn by prioritizing its R&D efforts. CEO Nichtberger needs t...Starting at €8.20